Zandelisib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Zandelisib, covering 2023-12-13 to 2024-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) [Phase 2]